Navigation Links
Renaissance Laser & Vein Institute (LaserandVeinclinic.com) Provides Top Notch 'Varicose Vein Treatment'
Date:2/17/2009

Los Angeles based Renaissance Laser & Vein Institute eliminates varicose and spider veins rapidly with new laser treatment

THOUSAND OAKS, Calif., Feb. 17 /PRNewswire/ -- Southern California based Renaissance Laser & Vein Institute offers patients an easy and effective method for eliminating painful and unsightly veins. As people age, deterioration of proper vein structure is a common problem. Sun damage, loss of collagen and natural causes including pregnancy all contribute to visible varicose, spider and reticular veins. Varicose veins are the most common of all complaints, since the bulging veins pose a health threat along with their unfavorable appearance. Faulty valves in the veins cause bulging and twisting that, if left untreated, increases potential for permanent skin pigmentation as well as swelling and ulcers on the legs and feet.

Traditional varicose vein treatment methods such as vein stripping are painful, requiring multiple incisions and extended healing time. New vein treatment options, such as those offered by Renaissance Laser & Vein Institute, utilize the help of sophisticated lasers to eliminate the pain and downtime associated with traditional vein treatment. The new treatment procedure involves no incisions and only local anesthesia for a quick and easy procedure. A laser catheter is inserted through a small needle, which allows the laser's energy to obliterate the vein. This new laser vein elimination procedure has revolutionized treatment of varicose veins, providing a better solution to sufferers everywhere.

The Renaissance Laser & Vein Institute is proud to offer laser vein treatments for spider and reticular veins as well. Though these veins do not pose a health threat, patients often wish to eliminate them for cosmetic reasons. Spider veins are common on the legs and on the face, which makes them difficult to hide or cover up with makeup. The Renaissance L
'/>"/>

SOURCE Renaissance Laser & Vein Institute
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. ConsumerLab.com Study On Revatrol NOT Based on Current Formulation - the Revatrol Sample Used Was More Than Nine Months Out-Of-Date, says Renaissance Health Publishing
2. Renaissance Health Publishing, LLC Asks Key Credibility Questions of ConsumerLab.com
3. Renaissance Health Publishing, LLC Warns the Public that ConsumerLab.com is Not Independent and Labels the CL Seal of Approval a Worthless, Paid-For Advertising Gimmick
4. The Quantum Group Announces State Approval of TPA Application for Subsidiary Company Renaissance Administrative Solutions, Inc.
5. Renaissance Laser & Vein Institute (LaserandVeinclinic.com) Pearl Treatment
6. Laser blasts viruses in blood
7. Skin Cooling After Laser Treatment Could Leave Marks
8. Prize for Cutting-Edge Laser Innovations
9. VNUS Medicals Patent Lawsuit Against Laser Competitors to Proceed to Trial
10. OmniGuide Announces Launch of LightPath(TM) CO2 Laser Fiber
11. Lumenis(R) Introduces the Newest Innovations in Fractional CO2 Laser Skin Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... of three important studies have been published in the ... the Congress of Neurological Surgeons . The ... , a part of Wolters Kluwer Health . ... artificial neural networks (ANNs) may improve the ability to ... study in the June Neurosurgery supports increased ...
(Date:6/19/2013)... 2013) In early April, senior leaders from medical, ... Connecticut, to discuss one question: how can first responders ... , The preliminary results of this discussion are now ... The Hartford Consensus ," a concept paper published in ... of Trauma and Acute Care Surgery , official ...
(Date:6/19/2013)... Could drugs that block the body,s system for repairing ... to health? As unlikely as it may seem, those ... and breast cancers driven by a mutation in BRCA, ... revealed she carries the mutation. The compounds, termed PARP ... the current edition of Chemical & Engineering News ...
(Date:6/19/2013)... 19, 2013 PREFERRED Therapy Providers, Inc. ... Arizona to offer a new Medicare Advantage Plan ... Paz, Yavapai and Mohave, Arizona counties. The agreement takes ... effective January 1, 2013 and Maricopa and Pima counties ... Inc., the parent company of WellCare of Arizona has ...
(Date:6/19/2013)... Kansas City will host its first Ciclovia event on Sept. ... section of Main Street in the midtown area will be restricted ... The Main Street Corridor Development and BikeWalkKC ... join the ranks of dozens of cities across the US and ... vibrancy and active lifestyles. , “Ciclovia is the perfect event for ...
Breaking Medicine News(10 mins):Health News:Neurosurgery publishes findings of 3 important studies in June issue 2Health News:Neurosurgery publishes findings of 3 important studies in June issue 3Health News:Hartford consensus aims to improve survival after mass shootings 2Health News:PREFERRED Therapy Providers, Inc. and WellCare of Arizona Finalize Their Agreement to Offer Medicare Advantage Plan to PREFERRED's Arizona Provider Network 2Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 2Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 3
... shows , , THURSDAY, Sept. 13 (HealthDay News) -- The HIV ... of sexual partners, U.S. researchers report. , More than half ... 2005 were among gay men, a team at the University ... in five gay men living in cities may be HIV-positive. ...
... Clinic,s,Multidisciplinary Simulation Center is now one of 11 ... be accredited by,the American College of Surgeons (ACS). ... advance medical education that will improve patient,safety by ... pace with,rapidly changing technologies. Mayo,s 10,000-square-foot, state-of-the-art ...
... Drug Control Policy to Include Meth Project ... of New Anti-Methamphetamine Initiative, PALO ALTO, Calif., Sept. 13 ... have been,selected by the White House Office of National Drug ... campaign. The Anti-Meth Campaign was unveiled today by ONDCP ...
... Lowering Kevin Everett,s body temperature helped protect his spinal ... -- As Buffalo Bills football player Kevin Everett was ... with a life-threatening spinal cord injury, he was already ... paralysis. , Everett,s spinal cord was damaged in his ...
... been named,mid-Atlantic region sales executive for AllOne Health ... their employees to take,greater control over their health ... employers alike. (Photo: http://www.newscom.com/cgi-bin/prnh/20070912/NEW120 ) ... Nicholas Hanchak, M.D.,Decker joins the team being headed ...
... Ensure Company Data Safe, Provide Alternate Operations ... Facility in Case ... largest,provider of business services to orthodontic and dental practices,worldwide, has ... Texas, as part of the company,s efforts to strengthen its,infrastructure ...
Cached Medicine News:Health News:Number of Partners Doesn't Explain Gay HIV Rate 2Health News:Number of Partners Doesn't Explain Gay HIV Rate 3Health News:Mayo Clinic Multidisciplinary Simulation Center Receives Distinction as an ACS-Accredited Education Institute 2Health News:Mayo Clinic Multidisciplinary Simulation Center Receives Distinction as an ACS-Accredited Education Institute 3Health News:Meth Project Advertisements Selected for National Prevention Campaign 2Health News:Meth Project Advertisements Selected for National Prevention Campaign 3Health News:Novel Cooling Therapy May Have Aided Injured Football Player 2Health News:Novel Cooling Therapy May Have Aided Injured Football Player 3Health News:Novel Cooling Therapy May Have Aided Injured Football Player 4Health News:Frances Decker Named Mid-Atlantic Region Sales Executive for AllOne Health Management Solutions 2Health News:OrthoSynetics(TM) Opens New Data Center, Colocation Facility 2
(Date:6/19/2013)... MUMBAI, India , June 19, ... Book Bureau has recently added DrugPatentWatch ... Databases. ( http://www.bharatbook.com/drugpatentwatch-tour.pdf ) ... DrugPatentWatch provides comprehensive information on pharmaceutical, ... value-added information supports the critical business ...
(Date:6/19/2013)... --  Nektar Therapeutics (Nasdaq: NKTR ) today ... study for NKTR-181, a first-in-class, opioid analgesic molecule ... slow rate of entry is designed to reduce the euphoria ... current opioid analgesics. 1 In the study data being ... in "drug liking" and "feeling high" scores and had highly ...
(Date:6/19/2013)... June 19, 2013 BD Biosciences, a segment of ... a leading global medical technology company, today announced the launch ... latest in its line of high-performance research flow cytometers. ... multicolor analysis with the most compact footprint in its class ... a height of 30" (76.2 cm). Recognizing that space is ...
Breaking Medicine Technology:Drug Patent Watch 2Drug Patent Watch 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 2Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 3Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 4Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 5Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 6Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 7Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 8Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence 9New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: